Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Metformin prevents ischemia reperfusion-induced oxidative stress in the fatty liver by attenuation of reactive oxygen species formation

M. Cahova, E. Palenickova, H. Dankova, E. Sticova, M. Burian, Z. Drahota, Z. Cervinkova, O. Kucera, C. Gladkova, P. Stopka, J. Krizova, Z. Papackova, O. Oliyarnyk, L. Kazdova,

. 2015 ; 309 (2) : G100-11. (Gastrointestinal and liver physiology) [pub] 20150604

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15031329

Nonalcoholic fatty liver disease is associated with chronic oxidative stress. In our study, we explored the antioxidant effect of antidiabetic metformin on chronic [high-fat diet (HFD)-induced] and acute oxidative stress induced by short-term warm partial ischemia-reperfusion (I/R) or on a combination of both in the liver. Wistar rats were fed a standard diet (SD) or HFD for 10 wk, half of them being administered metformin (150 mg·kg body wt(-1)·day(-1)). Metformin treatment prevented acute stress-induced necroinflammatory reaction, reduced alanine aminotransferase and aspartate aminotransferase serum activity, and diminished lipoperoxidation. The effect was more pronounced in the HFD than in the SD group. The metformin-treated groups exhibited less severe mitochondrial damage (markers: cytochrome c release, citrate synthase activity, mtDNA copy number, mitochondrial respiration) and apoptosis (caspase 9 and caspase 3 activation). Metformin-treated HFD-fed rats subjected to I/R exhibited increased antioxidant enzyme activity as well as attenuated mitochondrial respiratory capacity and ATP resynthesis. The exposure to I/R significantly increased NADH- and succinate-related reactive oxygen species (ROS) mitochondrial production in vitro. The effect of I/R was significantly alleviated by previous metformin treatment. Metformin downregulated the I/R-induced expression of proinflammatory (TNF-α, TLR4, IL-1β, Ccr2) and infiltrating monocyte (Ly6c) and macrophage (CD11b) markers. Our data indicate that metformin reduces mitochondrial performance but concomitantly protects the liver from I/R-induced injury. We propose that the beneficial effect of metformin action is based on a combination of three contributory mechanisms: increased antioxidant enzyme activity, lower mitochondrial ROS production, and reduction of postischemic inflammation.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15031329
003      
CZ-PrNML
005      
20250618145547.0
007      
ta
008      
151005s2015 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1152/ajpgi.00329.2014 $2 doi
035    __
$a (PubMed)26045616
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Cahova, Monika $u Center for Experimental Medicine, Department of Metabolism and Diabetes, Charles University, Prague, Czech Republic; monika.cahova@ikem.cz.
245    10
$a Metformin prevents ischemia reperfusion-induced oxidative stress in the fatty liver by attenuation of reactive oxygen species formation / $c M. Cahova, E. Palenickova, H. Dankova, E. Sticova, M. Burian, Z. Drahota, Z. Cervinkova, O. Kucera, C. Gladkova, P. Stopka, J. Krizova, Z. Papackova, O. Oliyarnyk, L. Kazdova,
520    9_
$a Nonalcoholic fatty liver disease is associated with chronic oxidative stress. In our study, we explored the antioxidant effect of antidiabetic metformin on chronic [high-fat diet (HFD)-induced] and acute oxidative stress induced by short-term warm partial ischemia-reperfusion (I/R) or on a combination of both in the liver. Wistar rats were fed a standard diet (SD) or HFD for 10 wk, half of them being administered metformin (150 mg·kg body wt(-1)·day(-1)). Metformin treatment prevented acute stress-induced necroinflammatory reaction, reduced alanine aminotransferase and aspartate aminotransferase serum activity, and diminished lipoperoxidation. The effect was more pronounced in the HFD than in the SD group. The metformin-treated groups exhibited less severe mitochondrial damage (markers: cytochrome c release, citrate synthase activity, mtDNA copy number, mitochondrial respiration) and apoptosis (caspase 9 and caspase 3 activation). Metformin-treated HFD-fed rats subjected to I/R exhibited increased antioxidant enzyme activity as well as attenuated mitochondrial respiratory capacity and ATP resynthesis. The exposure to I/R significantly increased NADH- and succinate-related reactive oxygen species (ROS) mitochondrial production in vitro. The effect of I/R was significantly alleviated by previous metformin treatment. Metformin downregulated the I/R-induced expression of proinflammatory (TNF-α, TLR4, IL-1β, Ccr2) and infiltrating monocyte (Ly6c) and macrophage (CD11b) markers. Our data indicate that metformin reduces mitochondrial performance but concomitantly protects the liver from I/R-induced injury. We propose that the beneficial effect of metformin action is based on a combination of three contributory mechanisms: increased antioxidant enzyme activity, lower mitochondrial ROS production, and reduction of postischemic inflammation.
650    _2
$a adenosintrifosfát $x metabolismus $7 D000255
650    _2
$a zvířata $7 D000818
650    _2
$a antiflogistika $x farmakologie $7 D000893
650    _2
$a antioxidancia $x farmakologie $7 D000975
650    _2
$a apoptóza $x účinky léků $7 D017209
650    _2
$a cytoprotekce $7 D019610
650    _2
$a dieta s vysokým obsahem tuků $7 D059305
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a energetický metabolismus $x účinky léků $7 D004734
650    _2
$a mediátory zánětu $x metabolismus $7 D018836
650    _2
$a peroxidace lipidů $x účinky léků $7 D015227
650    _2
$a játra $x účinky léků $x metabolismus $x patologie $7 D008099
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a metformin $x farmakologie $7 D008687
650    _2
$a jaterní mitochondrie $x účinky léků $x metabolismus $x patologie $7 D008930
650    _2
$a nealkoholová steatóza jater $x farmakoterapie $x etiologie $x metabolismus $x patologie $7 D065626
650    _2
$a oxidační stres $x účinky léků $7 D018384
650    _2
$a potkani Wistar $7 D017208
650    _2
$a reaktivní formy kyslíku $x metabolismus $7 D017382
650    _2
$a reperfuzní poškození $x etiologie $x metabolismus $x patologie $x prevence a kontrola $7 D015427
650    _2
$a časové faktory $7 D013997
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Palenickova, Eliska $u Center for Experimental Medicine, Department of Metabolism and Diabetes, Charles University, Prague, Czech Republic; Department of Cell Biology, Faculty of Science, Charles University, Prague, Czech Republic;
700    1_
$a Dankova, Helena $u Center for Experimental Medicine, Department of Metabolism and Diabetes, Charles University, Prague, Czech Republic;
700    1_
$a Sticova, Eva $u Clinical and Transplant Pathology Department, Charles University, Prague, Czech Republic;
700    1_
$a Burian, Martin $u Department of Diagnostic and Interventional Radiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic;
700    1_
$a Drahota, Zdeněk, $d 1932- $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic; $7 jn20000400531
700    1_
$a Cervinkova, Zuzana $u Department of Physiology, Charles University in Prague, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic;
700    1_
$a Kucera, Otto $u Department of Physiology, Charles University in Prague, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic;
700    1_
$a Gladkova, Christina $u Department of Chemistry, University of Cambridge, Cambridge, United Kingdom; and.
700    1_
$a Stopka, Pavel $u Institute of Inorganic Chemistry Academy of Science CR, Husinec-Rez, Czech Republic.
700    1_
$a Krizova, Jana $u Institute of Inorganic Chemistry Academy of Science CR, Husinec-Rez, Czech Republic.
700    1_
$a Papackova, Zuzana $u Center for Experimental Medicine, Department of Metabolism and Diabetes, Charles University, Prague, Czech Republic;
700    1_
$a Oliyarnyk, Olena $u Center for Experimental Medicine, Department of Metabolism and Diabetes, Charles University, Prague, Czech Republic;
700    1_
$a Kazdová, Ludmila, $d 1938-2025 $u Center for Experimental Medicine, Department of Metabolism and Diabetes, Charles University, Prague, Czech Republic; $7 xx0053119
773    0_
$w MED00000287 $t American journal of physiology: Gastrointestinal and liver physiology. Gastrointestinal and liver physiology $x 1522-1547 $g Roč. 309, č. 2 (2015), s. G100-11
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26045616 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20151005 $b ABA008
991    __
$a 20250618145537 $b ABA008
999    __
$a ok $b bmc $g 1092205 $s 914455
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 309 $c 2 $d G100-11 $e 20150604 $i 1522-1547 $m American journal of physiology: Gastrointestinal and liver physiology $n Am J Physiol Gastrointest Liver Physiol $x MED00000287 $o Gastrointestinal and liver physiology
LZP    __
$a Pubmed-20151005

Najít záznam

Citační ukazatele

Možnosti archivace